Hormonally Related Non-Neoplastic Conditions of the Ovary

  • H.-E. Stegner
Part of the Current Topics in Pathology book series (CT PATHOLOGY, volume 78)

Abstract

There are few pathological alterations of the ovary that do not in some way influence the hormonal homeostasis either by directly affecting the compartment of steroid secreting cells or by interacting with gonadotropic hormones or ovarian steroids at various levels of the regulatory axis. Owing to their origin from a common blastema, most ovarian cells are capable of steroid biosynthesis, but there is a changing pattern of ovarian steroidogenesis and of response to gonadotropic stimulation during the different periods of female life. Similar pathogenetic stimuli may lead to different responses depending on the age and the actual structural condition of the gonads. Some of these hormonally related conditions are discussed in this chapter. Unlike true neoplasms and other pathological conditions of the ovary, there exists no clear classification of hormonally related, non-neoplastic ovarian disease. A broad spectrum of conditions with different pathogenesis and morphology will be considered in this chapter.

Keywords

Progesterone Estradiol Teratoma Dock Thyroiditis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adashi FY, Rock JA, Guzick D, Wentz AC, Jones GS, Jones HW (1981) Fertility following bilateral ovarian wedge resection: a critical analysis of 90 consecutive cases of the polycystic ovary syndrom. Fertil Steril 56: 320–325.Google Scholar
  2. Adashi EY (1984) Clomiphene citrate: Mechanism (s) and site (s) of action — a hypothesis revisited. Fertil Steril 42: 331–344.PubMedGoogle Scholar
  3. Barakat BY, Ances IF, Tang CK, Fajer AB (1979) 46,XY gonadal dysgenesis with secondary amenorrhea, virilization, and bilateral gonadoblastoms. South Med J 72: 1163–1165.PubMedCrossRefGoogle Scholar
  4. Bettendorf G, Insler V (1970) Clinical application of human gonadotropins (eds) G. Thieme, Stuttgart.Google Scholar
  5. Blaustein A, Kantius M, Kaganowicz A, Pervez N, Wells J (1982) Inclusions in ovaries of females aged 1–30 years. Int J Gynecol Pathol 1: 145–154.PubMedCrossRefGoogle Scholar
  6. Bonakdar MI, Peisner DB (1980) Gonadoblastoma with a 45,X karyotype Obstet Gynecol 56: 748–750.Google Scholar
  7. Bur ME, Greene GL, Press MF (1987) Estrogen receptor localization in formalin-fixed, paraffin-embedded endometrium and endometriotic tissues. Int J Gynecol Pathol 6: 140–151.PubMedCrossRefGoogle Scholar
  8. Campenhout J van, Vauclair R, Maraghi K (1972) Gonadotropin-resistant ovaries in primary amenorrhea. Obstet Gynecol 40: 6–12.PubMedGoogle Scholar
  9. Channing CP, Anderson LD, Hoover DJ, Kolena J, Osteen KG, Pomerantz SH Tanabe K (1982) The role of nonsteroidal regulators in control of oocyte and follicular maturation. Recent Progr Horm Res 38: 331–408.PubMedGoogle Scholar
  10. Chervenak FA, Castadot MJ, Wiedermann J, Sedlis A (1980) Massive ovarian edema: review of world literature and report of two cases. Obstet Gynecol Surv 35: 677–684.PubMedGoogle Scholar
  11. Chow KK, Choo HT (1984) Ovarian hyperstimulation syndrome with clomiphenecitrate. Case report. Brit J Obstet Gynaecol 91: 1051–1052.CrossRefGoogle Scholar
  12. Clement PB, Scully RE (1979) Large solitary luteinized follicle cyst of pregnancy and puerperium. A clinico-pathological analysis of 8 cases. Am J Surg Pathol 4: 431–438.CrossRefGoogle Scholar
  13. Cohen MB (1979) Surgical management of infertility in the polycystic ovary syndrome. In: Givens JR (ed) The infertile female. Yearbook Med Publ, Chicago.Google Scholar
  14. Coulam CB, Gallenberg MM, Webb MJ, Gaffey TA (1982) The absence of H-Y antigen in XY gonads grossly resembling ovaries. Am J Obstet Gynecol 142: 925.PubMedGoogle Scholar
  15. Curtis WR, White BJ, Lucky AW, Roche-Bender N, Knab DR, Johansonbaugh RE (1980) Gonadal dysgenesis with mosaicism and a non-fluorescent Y chromosome: Report of two cases with correlation of clinical pathologic, and cytogenetic findings. Am J Obstet Gynecol 136: 639–645.PubMedGoogle Scholar
  16. Czernobilsky B, Silverman BB, Mikuta JJ (1970) Endometrioid carcinoma of the ovary. A clinicopathologic study of 75 cases. Cancer 26: 1141–1152.PubMedCrossRefGoogle Scholar
  17. Czernobilsky B, Morris WJ (1979) A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes. Obstet Gynecol 53: 318–328.PubMedGoogle Scholar
  18. Damjanov I, Klauber G (1980) Microscopic gonadoblastoma in dysgenetic gonad of an infant: an ultrastructural study. Urology 15: 605–609.PubMedCrossRefGoogle Scholar
  19. Dewhurst CJ, DeKoss EB, Ferreira HP (1975) The resistent ovary syndrome. Brit J Obst Gynecol 82: 341–345.CrossRefGoogle Scholar
  20. Dignam WJ, Pion RJ, Lamb EJ (1964) Plasma androgens in women. II. Patients with polycystic ovaries and hirsutism. Acta Endocrinol (Kbh) 45: 254–271.Google Scholar
  21. DiZerega GS, Goebelsmann U, Nakamura R (1982) Identification of protein (s) secreted by the preovulatory ovary which suppresses the follicle response to gonadotropins. J Clin Endocrinol Metabolism 54: 1091–1096.CrossRefGoogle Scholar
  22. Dockerty MB (1962) Malignancy complicating endometriosis. Am J Obstet Gynecol 83: 175–179.PubMedGoogle Scholar
  23. Erickson GF, Hsueh AJW, Quigley ME, Rebar RW, Yen SSC (1979) Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries. J Clin Endocr Metab 49: 514–519.PubMedCrossRefGoogle Scholar
  24. Ferreira HP, Clayton SG (1958) Three cases of malignant changes in endometriosis including two cases arising in rectovaginal septum. J Obstet Gynecol Br Emp 65: 41–44.CrossRefGoogle Scholar
  25. Gemzell C, Disczfalusy E, Tillinger KG (1958) Clinical effect of human pituitary follicle stimulating hormone (FSH). J Clin Endocrinol 18: 1333–1348.CrossRefGoogle Scholar
  26. Gemzell C (1965) Induction of ovulation with human gonadotrophins. Recent Progr Horm Res 21: 179–204.PubMedGoogle Scholar
  27. Gemzell C (1970) Experiences with human pituitary gonadotrophins in infertile women. In: Butler JK (ed) Development in the Pharmacology and Clinical Uses of Human Gonadotrophins. SD Searle & Co. High Wycombe, England.Google Scholar
  28. Goldzieher JW, Axelrod LR (1963) Clinical and biochemical features of polycystic ovarian disease. Fertil Steril 14: 631–641.PubMedGoogle Scholar
  29. Gunnala S, Eskin BA, Bartuska DG (1981) Pure gonadal dysgenesis with microscopic ovarian streak and gonadoblastoma. Obstet Gynecol 57: 58–61.Google Scholar
  30. Hall JL, Wachtel SS (1980) Primary sex determination: genetics and biochemistry. Mol Cell Biochem 33: 49–66.PubMedCrossRefGoogle Scholar
  31. Haseltine FP, Ohno S (1981) Mechanisms of gonadal differentiation. Science 211: 1272–1278.PubMedCrossRefGoogle Scholar
  32. Hjörtrup A, Kehler H, Lockwood K, Hasner E (1983) Long term clinical effects of ovarian wedge resection in polycystic ovarian syndrome. Acta Obstet Cynecol Scand 62: 55–57.CrossRefGoogle Scholar
  33. Holtz G, Kling OR, Miller DD, Wilson DA (1982) Ovarian hyperstimulation syndrome caused by clomiphene citrate. South Med J 75: 368–370.PubMedCrossRefGoogle Scholar
  34. Insler V, Melmed H, Mshiah S, Monselise M, Lunenfeld B, Rabau E (1968) Functional classification of patients selected for gonadotropic therapy. Obstet Gynecol 32: 620–626.PubMedGoogle Scholar
  35. Irvine WJ, Chan MM, Scarth L et al. (1968) Immunological aspects of premature ovarian failure associated with idiopathic Addison’s disease. Lancet 2: 883–887.PubMedCrossRefGoogle Scholar
  36. Irvine WJ, Chan MMW, Scarth C (1969) The further characterization of autoantibodies reactive with extra-adrenal steroid-producing cells in patients with adrenal disorders. Clin Exp Immunol 4: 489–503.PubMedGoogle Scholar
  37. Ito T, Horton R (1971) The source of plasma dihydrotestosterone in man. J Clin Invest Metab 50: 1621–1627.CrossRefGoogle Scholar
  38. Janovski NA, Paramanandhan TL (1973) Ovarian tumors. Tumor and tumor-like conditions of the ovaries, fallopian tubes and ligaments of the uterus. G. Thieme, Stuttgart.Google Scholar
  39. Kalstone CE, Jaffe RB, Abell MR (1970) Massive edema of the ovary simulating fibroma. Obstet Gynecol 34: 564–571.Google Scholar
  40. Kato J, Kobayashi F, Villec CA (1968) Effect of clomiphene on the uptake of estradiol by the anterior hypothalamus und hypophysis. Endocrinol 82: 1049–1052.CrossRefGoogle Scholar
  41. Kinch RAH, Plunket ER, Smout MS, Carl DH (1965) Primary ovarian failure. Amer J Obstet Gynecol 91: 630–644.Google Scholar
  42. Kim MH (1974) “Gonadotropin-resistent ovaries” syndrome in association with secondary amenorrhea. Am J Obstet Gynecol 120: 257–263.PubMedGoogle Scholar
  43. King CR, Magensis E, Bennett S (1979) Pregnancy and the Turner Syndrome. Obstet Gynecol 52: 617–624.Google Scholar
  44. Kirschner MA, Jacobs J (1971) Combined ovarian and abdominal vein catheterization to determine site (s) of androgen overproduction in hirsute women. J Clin Endocrinol Metab 33: 199–209.PubMedCrossRefGoogle Scholar
  45. Kistner RW (1966) Use of clomiphene citrate, human chorionic gonadotropin, and human menopausal gonadotropin for induction of ovulation in the human female. Fertil Steril 17: 569–583.PubMedGoogle Scholar
  46. Kleiner GK, Solomon L, Greston WM, Lev-Gur M (1978) Wedge resection in massive edema of the ovary. Am J Obstet Gynecol 137: 107.Google Scholar
  47. Koninckx PR (1981) New aspects of ovarian function in man and in rat. Thesis, Katholieke Universiteit Leuven, Fakulteit Geneeskunde, Belgium.Google Scholar
  48. Kurman RJ, Andrade D, Goebelsmann U, Taylor CR (1978) An immunohistological study of steroid localization in Sertoli-Leydig tumors of the ovary and testis. Cancer (Philad) 42: 1772–1783.CrossRefGoogle Scholar
  49. Kurman RJ, Goebelsmann U, Taylor CR, Bchir MD (1981) Localization of steroid hormones in functional ovarian tumors. In: DeLellis RA: Diagnostic Immunohistochemistry. Masson, Paris.Google Scholar
  50. Kurman RJ, Ganjei P, Nadji M (1984) Contributions of immunocytochemistry to the diagnosis and study of ovarian neoplasms. Int J Gynecol Pathol 3: 3–26.PubMedCrossRefGoogle Scholar
  51. Lintern-Moore S, Peters H, Moore GPM, Faber M (1974) Follicular development in the infant human ovary. J Reprod Fert 39: 53–64.CrossRefGoogle Scholar
  52. Lunan-Burnett C, Klopper A (1975) Antiestrogens: A review. Clin Endocr 4: 551–572.CrossRefGoogle Scholar
  53. Luzzatto R, Murray JM, Gallager HS (1979) Gonadoblastoma associated with malignant teratoma. South Med J 72: 624–627.PubMedCrossRefGoogle Scholar
  54. Mahesh VB, Greenblatt RB (1964) Steroid secretions in the normal and polycystic ovary. Recent Progr Horm Res 20: 341–394.PubMedGoogle Scholar
  55. McArdle CR, Seibel M, Weinstein F, Hann LE, Nickerson C, Taymor ML (1983) Induction of ovulation monitored by ultrasound. Radiology 148: 809–812.PubMedGoogle Scholar
  56. Moltz L, Schwartz U, Pickartz H, Hammerstein J, Wolf U (1981) XY gonadal dysgenesis: aberrant testicular differentiation in the presence of H-Y antigen. Obstet Gynecol 58: 17–25.PubMedGoogle Scholar
  57. Moraes-Ruehsen M, Blizzard RM, Garcia-Bunuel R, Jones GS (1972) Autoimmunity and ovarian failure. Am J Obstet Gynecol 112: 693–703.PubMedGoogle Scholar
  58. Nassar TR, Virgilio LA, Abdul-Karim RW (1976) Massive edema of the ovary. A case report and a review of the literature. Obstet Gynecol 47: 775–805.Google Scholar
  59. Norris HJ, Taylor JB (1967) Nodular theca lutein hyperplasia of pregnancy (so-called “pregnancy luteoma”). A clinical and pathologic study of 15 cases. Am J Clin Pathol 47: 557–566.PubMedGoogle Scholar
  60. Peters H (1980) The Ovary. Paul Elek (ed) Granada. London.Google Scholar
  61. Pfleiderer A, Teufel G (1968) Incidence and histochemical investigation of enzymatically active cells in stroma of ovarian tumors. Am J Obstet Gynecol 102: 997.PubMedGoogle Scholar
  62. Pickartz H, Moltz L, Altenähr E (1980) XY (H-Y) Gonadal Dysgenesis. Virchows Arch path Anat 389: 103–112.Google Scholar
  63. Rabau E, Serr DM, Mashiah S, Insler V, Salomy M, Lunenfeld B (1967) Current concepts in the treatment of anovulation. Br Med J 4: 446–449.PubMedCrossRefGoogle Scholar
  64. Rebar RW (1983) The reproductive age: chronic anovulation. In: Serra GB (ed) The Ovary. Raven Press, New York.Google Scholar
  65. Rebar RW, Rebar MF, Silva De SA (1983) The reproductive age: premature ovarian failure. In: Serra GB (ed) The ovary. Raven Press, New York.Google Scholar
  66. Ridley JH (1966) Primary adenocarcinoma in implant of endometriosis. Obstet Gynecol 77: 261–267.Google Scholar
  67. Robboy STJ, Miller TH, Donahoe PK, Jahre C, Welch WR, Haseltine FP, Miller WA, Atkins L, Crawford JD (1982) Dysgenesis of testicular and streak gonads in the syndrome of mixed gonadal dysgenesis. Perspective derived from a clinicopathologic analysis of twenty-one cases. Hum Pathol 13: 700–716.PubMedCrossRefGoogle Scholar
  68. Roth LM (1971) Massive ovarian edema with stroma luteinization: a nearly recognized virilizing syndrome apparently related to partial torsion of the mesovarium. Am J Clin Path 55: 757–760.PubMedGoogle Scholar
  69. Scully RE (1953) Gonadoblastom. A gonadal tumor related to dysgerminoma (seminoma) and capable of sex hormone production. Cancer 6: 455–681.PubMedCrossRefGoogle Scholar
  70. Scully RE (1970) Gonadoblastoma, a review of 74 cases. Cancer 25: 1340–1356.PubMedCrossRefGoogle Scholar
  71. Scully RE (1971) Case records of the Massachusetts General Hospital (case 24 — 1971). N Engl J Med 284: 1369–1375.CrossRefGoogle Scholar
  72. Scully RE (1979) Atlas of tumor pathology. Second series, Fasc 16. Tumors of the ovary and maldeveloped gonads. Armed Forces Inst. of Pathol Washington D.C..Google Scholar
  73. Scully RE, Cohen RB (1964) Oxidative-enzyme activities in normal and pathologic human ovaries. Obstet Gynecol 24: 667.PubMedGoogle Scholar
  74. Singh RP, Carr DH (1966) The anatomy and histology of XO human embryos and fetuses. Anat Rec 155: 369–381.PubMedCrossRefGoogle Scholar
  75. Singh RP, Carr DH (1967) Anatomic findings in human abortions of known chromosomal constitution. Obstet Gynecol 29: 806.PubMedGoogle Scholar
  76. Schenker JG, Weinstein D (1978) Ovarian hyperstimulation syndrome: A current survey. Fertil Steril 30: 255–268.PubMedGoogle Scholar
  77. Schneider HPG, Hanker JP, Goeser R (1983) Das gestörte Corpus luteum. In: Zander J (ed) Die Sterilität. Urban und Schwarzenberg, München.Google Scholar
  78. Starup J, Sele V, Henriksen B (1971) Amenorrhea associated with increased production of gonadotrophins and a morphologically normal ovarian follicular apparatus. Acta Endocrinol 66: 248–256.PubMedGoogle Scholar
  79. Steiner MM, Hadaw SA (1964) Sexual precocity. Association with follicular cysts of ovary. Am J Dis Child 102: 28–36.Google Scholar
  80. Sternberg WH, Segaloff A, Gaskill CJ (1953) Influence of chorionic gonadotropin on human ovarian hilus cells (Leydig-like cells). J Clin Endocr 13: 139–153.PubMedCrossRefGoogle Scholar
  81. Sternberg WH, Barclay DL (1966) Luteoma of pregnancy. Am J Obstet Gynecol 95: 165–185.PubMedGoogle Scholar
  82. Stone SL, Pomerantz SH, Schwartz-Kripner A, Channing CP (1978) Biology of Reproduction 19: 585–592.PubMedCrossRefGoogle Scholar
  83. Taguchi O, Nishizuka Y, Sakagura T, Kojima A (1980) Autoimmune oophoritis in thymectomized mice: detection of circulating antibodies against oocytes. Clin exp Immunol 40: 540–553.PubMedGoogle Scholar
  84. Talerman A (1974) Gonadoblastoma associated with embryonal carcinoma. Obstet Gynecol 43: 138–142.PubMedGoogle Scholar
  85. Talerman A (1980) The pathology of gonadal neoplasms composed of germ cells and sex cord stroma derivations. Path Res Pract 170: 24–38.PubMedCrossRefGoogle Scholar
  86. Turner HH (1938) Syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 23: 566–574.CrossRefGoogle Scholar
  87. Vandenberg G, Yen SSC (1973) Effect of antiestrogenic action of clomiphene during menstrual cycle: Evidence for change in the feedback sensitivity. J Clin Endocrinol Metab 37: 356–365.PubMedCrossRefGoogle Scholar
  88. Vane De GW, Czekala NM, Judd HL, Yen SSC (1975) Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am J Obstet Gynecol 121: 496–500.Google Scholar
  89. Vasquez SB, Sotos JF, Kim MH (1982) Massive edema of the ovary and virilization. Obstet Gynecol 59: 95S–99S(6 Suppl).PubMedGoogle Scholar
  90. Wachtel SS (1979) The genetics of intersexuality: clinical and theoretic perspectives. Obstet Gynecol 54: 671–685.PubMedGoogle Scholar
  91. Wentz AC, Jones GS, Sapp KC (1976) Effect of clomiphene citrate on gonadotropin responses to LRH administration in secondary amenorrhea and oligomenorrhea. Obstet Gynecol 47: 677–683.PubMedGoogle Scholar
  92. Wolf U (1979) Gonadal dysgenesis and the HY-antigen. Report on 12 cases. Hum Genet 47: 269–277.PubMedCrossRefGoogle Scholar
  93. Woodcock AS, Govan AD, Gouing NF, Langley FA, Anderson MC (1979) A report of the histological features in 12 cases of gonadoblastoma. Tumori 65: 181–189.PubMedGoogle Scholar
  94. Woodruff JD, Williams TJ, Goldberg B (1963) Hormone activity of the common ovarian neoplasm. Am J Obstet Gynecol 87: 679–698.PubMedGoogle Scholar
  95. Young RH, Scully RE (1984) Fibromatosis and massive edema of the ovary, possibly related entities: A report of 14 cases of fibromatosis and 11 cases of massive edema. Int J Gynecol Pathol 3: 153–178.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • H.-E. Stegner

There are no affiliations available

Personalised recommendations